Edition:
India

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

1.59USD
18 Oct 2019
Change (% chg)

$-0.10 (-5.92%)
Prev Close
$1.69
Open
$1.71
Day's High
$1.71
Day's Low
$1.58
Volume
15,503
Avg. Vol
25,094
52-wk High
$3.74
52-wk Low
$1.22

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.759
FY 2018 Dec '18 0.00 -0.731
Sep '18 0.00 -1.651
Jun '18 0.00 -1.687
Mar '18 0.00 -2.068
FY 2017 Dec '17 0.00 -3.220
Sep '17 0.00 -2.576
Jun '17 0.00 -2.319
Mar '17 0.00 -2.407
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-19 1 0.00 0.00 0.00 --
Quarter Ending Mar-20 1 0.00 0.00 0.00 --
Year Ending Dec-19 2 0.00 0.00 0.00 0.00
Year Ending Dec-20 2 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-19 2 -0.44 -0.43 -0.46 -1.30
Quarter Ending Mar-20 2 -0.34 -0.20 -0.48 --
Year Ending Dec-19 2 -2.40 -2.36 -2.45 -6.20
Year Ending Dec-20 2 -1.26 -0.81 -1.72 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.73 33.85
P/E High - Last 5 Yrs. -- 47.56 54.29
P/E Low - Last 5 Yrs. -- 27.30 28.22
Beta 1.16 1.00 0.99
Price to Sales (TTM) -- 6.00 7.90
Price to Book (MRQ) 1.35 3.84 4.38
Price to Tangible Book (MRQ) 1.17 4.14 5.07
Price to Cash Flow (TTM) -- 21.62 23.70
% Owned Institutions 49.25 0.79 1.78

Dividends

  Company industry sector
Dividend Yield -- 1.83 1.67
Dividend Yield - 5 Year Avg -- 1.47 1.37
Dividend 5 Year Growth Rate -- 6.74 6.82
Payout Ratio(TTM) -- 50.64 46.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 13.42 14.65
Sales (TTM) vs TTM 1 Yr. Ago -- 6.45 8.45
Sales - 5 Yr. Growth Rate -- 8.32 9.43
EPS (MRQ) vs Qtr. 1 Yr. Ago 63.31 18.49 19.40
EPS (TTM) vs TTM 1 Yr. Ago 52.60 -- --
EPS - 5 Yr. Growth Rate -- 5.66 7.15
Capital Spending - 5 Yr. Growth Rate 21.10 7.02 8.01

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.52 2.52
Current Ratio (MRQ) 5.04 3.55 3.52
LT Debt to Equity (MRQ) 0.00 11.64 12.61
Total Debt to Equity (MRQ) 0.01 16.17 17.64
Interest Coverage (TTM) -- 7.61 14.93

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.41 50.25
Gross Margin - 5 Yr. Avg. -- 50.53 51.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.64 16.42
Operating Margin (TTM) -- -2.19 -6.97
Operating Margin - 5 Yr. Avg. -- 13.94 11.87
Pre-Tax Margin (TTM) -- -2.50 -7.30
Pre-Tax Margin - 5 Yr. Avg. -- 18.73 15.72
Net Profit Margin (TTM) -- -6.21 -11.11
Net Profit Margin - 5 Yr. Avg. -- 14.06 11.11
Effective Tax Rate (TTM) -- 20.27 20.61
Effective Tax Rate - 5 Yr. Avg. -- 22.92 24.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 1,012,949,194 870,638,159
Net Income/Employee (TTM) -- 118,477,208 101,855,832
Receivable Turnover (TTM) -- 5.61 5.88
Inventory Turnover (TTM) -- 2.59 3.66
Asset Turnover (TTM) 0.00 0.88 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -121.07 10.57 10.25
Return on Assets - 5 Yr. Avg. -77.36 11.70 11.17
Return on Investment (TTM) -150.37 13.04 12.69
Return on Investment - 5 Yr. Avg. -112.41 14.80 14.15
Return on Equity (TTM) -210.13 14.12 17.13
Return on Equity - 5 Yr. Avg. -135.77 15.92 15.53
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 51.15 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellectar Biosciences Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.38 -4.12 54 47
13 Week -6.52 -9.18 55 34
26 Week 5.91 -6.73 72 15
52 Week -59.66 -62.17 13 66
YTD 38.71 14.92 86 20
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 49.25%
# of Holders: 20
Total Shares Held: 2,657,498
3 Mo. Net Change: 2,289,515
# New Positions: 4
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 0
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.